Trial intelligence / Profile preview

Avmacol Bioavailability and Pharmacodynamics in Head and Neck Cancer Survivors

NCT03182959Phase 1Completed

Sponsor
University of Arizona
Start
Apr 2017
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of broccoli seed and sprout extract in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by University of Arizona. Primary endpoint: Induction of NRF2 target gene transcripts in the oral mucosa at 4 months. Started Apr 2017; status: completed.

02

Drugs

broccoli seed and sprout extract
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT03182959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03182959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call